Meeting in Florence of RIETE Italy
New advances in VTE based on registry data were presented and discussed Once again, the specialists in venous thromboembolism pertaining to the Italian group of the RIETE Registry convened their annual meeting, with the aim of presenting new advances in the disease...
How oral anticoagulants work in patients excluded from clinical trials
A study by the RIETE Group analyses how these drugs work in pregnancy, cancer or cirrhosis, among other conditions Clinical trials of drugs exclude certain patients. Patients at risk of bleeding tend to be excluded, but these people still seek care and doctors often...
Novelties presented at the 13th VTE Multidisciplinary Forum
Studies on VTE and diabetes, on DOAC use or on VTE in young patients, among others One more year, now making thirteen years, the Venous Thromboembolism (VTE) Multidisciplinary Forum took place in Zaragoza. This meeting brings together Spanish doctors...
A daily injection of Enoxaparin, better than two
Un estudio del Grupo RIETE demuestra que una inyección diaria se asocia a menos hemorragias graves y menor mortalidad La enoxaparina es la heparina de bajo peso molecular más utilizada para la prevención de un episodio trombótico y la primera forma de...